BioPharmSignal logoBioPharmSignal

Biotech News

MATERIALISE AANDELENINKOOPPROGRAMMA

Materialise (MTLS)MaterialiseCompany update

Leuven – 27 juli 2026 – 22h00 CET Gereglementeerde informatie [1] Materialise rapporteert over de voortgang van haar op 30 oktober 2025 aangekondigde aandeleninkoopprogramma. 27 juli 2026 – Materialise NV (Euronext: MTLS) (Nasdaq: MTLS) (“Materialise”) (“de

Related news

MTLSMaterialise2026-08-13 10:45 EST

Materialise NV to Report Second Quarter and Half-Year 2026 Earnings on Thursday, August 27, 2026

MTLSMaterialise2026-07-27 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

View all latest news

Materialise

Additive-Manufacturing Technology Materialise is a global 3D-printing company providing software, production services and medical applications. Its technology supports the design and manufacture of complex parts from digital models. Medical Solutions The medical segment develops patient-specific surgical planning tools, anatomical...

Recent company news

MTLSMaterialise2026-08-13 10:45 EST

Materialise NV to Report Second Quarter and Half-Year 2026 Earnings on Thursday, August 27, 2026

MTLSMaterialise2026-07-27 20:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

MTLSMaterialise2026-07-27 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

MTLSMaterialise2026-07-20 20:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

MTLSMaterialise2026-07-20 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

Stock data

Close
6.61 USD
Market cap
401.4M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States